Literature DB >> 10844065

Decreased substance P concentrations in tears from patients with corneal hypesthesia.

M Yamada1, M Ogata, M Kawai, Y Mashima.   

Abstract

PURPOSE: To determine whether substance P concentrations in tears reflect corneal hypesthesia.
METHODS: Sixteen patients with unilateral corneal hypesthesia participated in this study. Unstimulated tears were collected from each eye of all subjects. Substance P concentrations in tears were measured by an enzyme immunoassay system.
RESULTS: Substance P concentrations in tears from the affected eye were lower than those in tears from the unaffected eye in all subjects. The mean concentration of substance P in tears from affected eyes was 197.7 +/- 69.5 pg/mL, markedly lower than those from unaffected eyes (333.2 +/- 74.6 pg/mL).
CONCLUSION: Substance P concentrations in tears, which are thought to reflect the neuropeptides levels in ocular tissues, can be used as an indicator of corneal denervation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844065     DOI: 10.1016/s0002-9394(00)00415-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

2.  [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

Authors:  P Herminghaus; G Geerling; D Hartwig; T Wedel; L Dibbelt
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

Review 3.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 4.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

5.  Degeneration and regeneration of corneal nerves in response to HSV-1 infection.

Authors:  Ana J Chucair-Elliott; Min Zheng; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-13       Impact factor: 4.799

6.  Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Naoyuki Morishige; Ryoji Yanai; Naoyuki Yamada; Jun Saito
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

7.  Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery.

Authors:  Maria Soledad Cortina; Jiucheng He; Tiffany Russ; Nicolas G Bazan; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

8.  Herpes zoster ophthalmicus.

Authors:  Srinivasan Sanjay; Philemon Huang; Raghavan Lavanya
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.972

Review 9.  Neuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Takayuki Baba; Shuichi Yamamoto
Journal:  Biomed Res Int       Date:  2016-12-01       Impact factor: 3.411

Review 10.  Neurotrophic factors and corneal nerve regeneration.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.